Alcolase
Alcolase is developing an enzyme-based technology designed to break down alcohol in the stomach before it is absorbed into the bloodstream.
Alcolase has raised €1.5M across 1 funding round from 5 investors, most recently a round in May 2026. Based in Copenhagen, Denmark; active in Healthtech. Data as of 28 Oct 2026.
Copenhagen, Denmarkwww.alcolase.com ↗
Total raised
€1.5M
€1,500,000
Funding rounds
1
Investors
5
distinct backers
Active since
2026-05
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDAlcolase — funding by year — interactive chart.
Data table
| Alcolase — funding by year | |
|---|---|
| 2026 | €1.5M |
Signals
High confidenceRaise-next likelihood23
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-18 | Other | €1.5M | Ada Ventures,Antler,Business Angels,Delphinus Venture Capital,Manigoff Invest | View deal → |
Investors
5Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData